- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 28th, 2007
There is some good news for insulin-dependent diabetic patients. Soon, they may not have to undergo painful jabs of insulin injection to keep their sugar levels under control. They may just have to pop in a tablet or gulp down a spoon of the medicine.
Thiruvananthapuram-based Sree Chitra Tirunal Institute of Medical Sciences and Technology has successfully demonstrated the possibility of developing an oral insulin preparation in experiments on mice and is now getting ready to conduct clinical trials with human subjects to establish its efficacy and viability.
Disclosing this, Director of the Institute K.Mohandas said the technology was based on the cutting edge science of nanotechnology. The technology, which recently cleared the proof of concept stage in experiments with mice, has been transferred to US Vitamin, a Mumbai-based company for further development. "We are now getting ready to conduct clinical trials in association with US Vitamin. We will decide whether it should be a tablet or in a liquid form later."
|Related News Press|
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015